{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:05:53Z","timestamp":1784531153689,"version":"3.55.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009673","name":"Gun and Bertil Stohnes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021594","name":"The Dementia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009473","name":"University of Malaga","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023731","name":"Junta de Andaluc\u00eda Consejer\u00eda de Salud y Consumo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005701","name":"Maja & JP \u00c5hl\u00e9n Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119629","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:01:01Z","timestamp":1781694061000},"page":"119629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3058-0635","authenticated-orcid":false,"given":"Beatriz","family":"Pacheco-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"L\u00f3pez-Gambero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luisa","family":"Gavito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Sanjuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7000-7556","authenticated-orcid":false,"given":"Simone","family":"Tambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Rodr\u00edguez","family":"de Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2026.119629_bib1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.biopha.2026.119629_bib2","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119629_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119629_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14415","article-title":"Soluble A\u03b2 pathology predicts neurodegeneration and cognitive decline independently on p-tau in the earliest Alzheimer's continuum: Evidence across two independent cohorts","volume":"21","author":"Cacciaglia","year":"2025","journal-title":"Alzheimer's. & Dement."},{"key":"10.1016\/j.biopha.2026.119629_bib5","article-title":"Comparative studies for amyloid beta degradation:\u201cNeprilysin vs insulysin\u201d,\u201cmonomeric vs aggregate\u201d, and \u201cwhole A\u03b240 vs its peptide fragments\u201d","volume":"30","author":"Kato","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000100355","article-title":"Amyloid-\u03b2 aggregation","volume":"4","author":"Finder","year":"2007","journal-title":"Neurodegener. Dis."},{"issue":"39","key":"10.1016\/j.biopha.2026.119629_bib7","doi-asserted-by":"crossref","first-page":"23515","DOI":"10.1074\/jbc.R115.677211","article-title":"Amyloid precursor protein (APP) metabolites APP intracellular fragment (AICD), A\u03b242, and tau in nuclear roles","volume":"290","author":"Multhaup","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2026.119629_bib8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-\u03b2 protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"issue":"35","key":"10.1016\/j.biopha.2026.119629_bib9","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1073\/pnas.0905127106","article-title":"Structure\u2013neurotoxicity relationships of amyloid \u03b2-protein oligomers","volume":"106","author":"Ono","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2026.119629_bib10","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1039\/c3sc22295k","article-title":"Synthetic dityrosine-linked \u03b2-amyloid dimers form stable, soluble, neurotoxic oligomers","volume":"4","author":"Kok","year":"2013","journal-title":"Chem. Sci."},{"issue":"5521","key":"10.1016\/j.biopha.2026.119629_bib11","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain A\u03b2 by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2353\/ajpath.2007.070105","article-title":"Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy","volume":"171","author":"Farris","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119629_bib13","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1074\/jbc.C200642200","article-title":"Alzheimer's disease \u03b2-amyloid peptide is increased in mice deficient in endothelin-converting enzyme","volume":"278","author":"Eckman","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2026.119629_bib14","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1074\/jbc.M112.422964","article-title":"Endothelin-converting enzymes degrade intracellular \u03b2-amyloid produced within the endosomal\/lysosomal pathway and autophagosomes","volume":"288","author":"Pacheco-Quinto","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2026.119629_bib15","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid \u03b2-protein, and the \u03b2-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119629_bib16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of \u03b2-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.biopha.2026.119629_bib17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/07853890.2016.1197416","article-title":"Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer\u2019s disease?","volume":"48","author":"Pivovarova","year":"2016","journal-title":"Ann. Med."},{"issue":"6012","key":"10.1016\/j.biopha.2026.119629_bib18","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS \u03b2-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biopha.2026.119629_bib19","first-page":"783","article-title":"Increased expression of the amyloid precursor \u03b2-secretase in Alzheimer's disease","volume":"51","author":"Holsinger","year":"2002","journal-title":"Ann. Neurol. Off. J. Am. Neurol. Assoc. Child. Neurol. Soc."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nm0103-3","article-title":"Elevated \u03b2-secretase expression and enzymatic activity detected in sporadic Alzheimer disease","volume":"9","author":"Yang","year":"2003","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.biopha.2026.119629_bib21","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181ffe4f6","article-title":"Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study","volume":"75","author":"Schrijvers","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/brain\/awac354","article-title":"Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study","volume":"146","author":"van Arendonk","year":"2023","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.biopha.2026.119629_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2967\/jnumed.113.132647","article-title":"Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation","volume":"55","author":"Roberts","year":"2014","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119629_bib24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.biopha.2026.119629_bib25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/brain\/awac309","article-title":"Cerebrovascular insulin receptors are defective in Alzheimer\u2019s disease","volume":"146","author":"Leclerc","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI64516","article-title":"Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes","volume":"123","author":"Ly","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.biopha.2026.119629_bib29","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s00125-016-4102-5","article-title":"Sequential cleavage of insulin receptor by calpain 2 and \u03b3-secretase impairs insulin signalling","volume":"59","author":"Yuasa","year":"2016","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.biopha.2026.119629_bib30","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2026.119629_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0083-6729(08)00622-5","article-title":"Structure, function, and regulation of insulin-degrading enzyme","volume":"80","author":"Hulse","year":"2009","journal-title":"Vitam. & Horm."},{"issue":"11","key":"10.1016\/j.biopha.2026.119629_bib32","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1074\/jbc.M609168200","article-title":"Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families","volume":"282","author":"Kim","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2026.119629_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/biomedicines8090295","article-title":"The biomedical uses of inositols: A nutraceutical approach to metabolic dysfunction in aging and neurodegenerative diseases","volume":"8","author":"L\u00f3pez-Gambero","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/156720512799015037","article-title":"Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease","volume":"9","author":"M. de la Monte","year":"2012","journal-title":"Curr. Alzheimer Res."},{"issue":"6865","key":"10.1016\/j.biopha.2026.119629_bib35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2026.119629_bib36","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1152\/physrev.00028.2012","article-title":"Phosphoinositides: tiny lipids with giant impact on cell regulation","volume":"93","author":"Balla","year":"2013","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119629_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/10942912.2011.631255","article-title":"Relationship between sugar profile and D-pinitol content of pods of wild and cultivated types of carob bean (Ceratonia siliqua L.)","volume":"17","author":"Turhan","year":"2014","journal-title":"Int. J. Food Prop."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1096\/fj.12-211896","article-title":"Protection against the synaptic targeting and toxicity of Alzheimer's-associated A\u03b2 oligomers by insulin mimetic chiro-inositols","volume":"27","author":"Pitt","year":"2013","journal-title":"FASEB J."},{"issue":"23","key":"10.1016\/j.biopha.2026.119629_bib39","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.3390\/nu16234186","article-title":"Therapeutic Efficacy of the Inositol D-Pinitol as a Multi-Faceted Disease Modifier in the 5\u00d7 FAD Humanized Mouse Model of Alzheimer\u2019s Amyloidosis","volume":"16","author":"Medina-Vera","year":"2024","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.biopha.2026.119629_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/1673-5374.379015","article-title":"Novel insights into D-Pinitol based therapies: a link between tau hyperphosphorylation and insulin resistance","volume":"19","author":"Medina-Vera","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"19","key":"10.1016\/j.biopha.2026.119629_bib41","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1111\/bph.15907","article-title":"d-Pinitol promotes tau dephosphorylation through a cyclin-dependent kinase 5 regulation mechanism: A new potential approach for tauopathies?","volume":"179","author":"Medina-Vera","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119629_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112994","article-title":"Dietary administration of D-chiro-inositol attenuates sex-specific metabolic imbalances in the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"150","author":"L\u00f3pez-Gambero","year":"2022","journal-title":"Biomed. & Pharmacother."},{"issue":"18","key":"10.1016\/j.biopha.2026.119629_bib43","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.3390\/nu17183024","article-title":"Early Oral Administration of D-Chiro-Inositol Reverses Hippocampal Insulin and Glutamate Signaling Deficits in the 3\u00d7 Tg Humanized Mouse Model of Alzheimer\u2019s Disease","volume":"17","author":"Pacheco-S\u00e1nchez","year":"2025","journal-title":"Nutrients"},{"issue":"01","key":"10.1016\/j.biopha.2026.119629_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1142\/S0192415X12500085","article-title":"Antioxidant and anti-inflammatory effects of a hypoglycemic fraction from Cucurbita ficifolia Bouch\u00e9 in streptozotocin-induced diabetes mice","volume":"40","author":"Roman-Ramos","year":"2012","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1073\/pnas.0509779103","article-title":"Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide","volume":"103","author":"Nascimento","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119629_bib46","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer's disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.biopha.2026.119629_bib47","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","article-title":"The'Arctic'APP mutation (E693G) causes Alzheimer's disease by enhanced A\u03b2 protofibril formation","volume":"4","author":"Nilsberth","year":"2001","journal-title":"Nat. Neurosci."},{"issue":"40","key":"10.1016\/j.biopha.2026.119629_bib48","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119629_bib49","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s12010-017-2468-6","volume":"183","author":"Pahrudin Arrozi","year":"2017","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"17","key":"10.1016\/j.biopha.2026.119629_bib50","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","article-title":"Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome","volume":"340","author":"Nestler","year":"1999","journal-title":"New. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12610-021-00131-x","article-title":"D-chiro-inositol, an aromatase down-modulator, increases androgens and reduces estrogens in male volunteers: A pilot study","volume":"31","author":"Monastra","year":"2021","journal-title":"Basic. Clin. Androl."},{"key":"10.1016\/j.biopha.2026.119629_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106295","article-title":"Transcending the amyloid-beta dominance paradigm in Alzheimer's disease: An exploration of behavioural, metabolic, and gut microbiota phenotypes in 5xFAD mice","volume":"187","author":"Medina-Vera","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-160046","article-title":"Pharmacological modulations of the serotonergic system in a cell-model of familial Alzheimer\u2019s disease","volume":"53","author":"Tajeddinn","year":"2016","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2026.119629_bib54","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.bbadis.2016.08.002","article-title":"Anthocyanins protect from complex I inhibition and APPswe mutation through modulation of the mitochondrial fission\/fusion pathways","volume":"1862","author":"Parrado-Fern\u00e1ndez","year":"2016","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2026.119629_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2024.102585","article-title":"Signal peptide peptidase-like 2b modulates the amyloidogenic pathway and exhibits an A\u03b2-dependent expression in Alzheimer's disease","volume":"235","author":"Maccioni","year":"2024","journal-title":"Progress. Neurobiol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119629_bib56","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.biopha.2026.119629_bib57","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.3390\/ijms22105365","article-title":"A negative energy balance is associated with metabolic dysfunctions in the hypothalamus of a humanized preclinical model of Alzheimer\u2019s disease, the 5XFAD mouse","volume":"22","author":"L\u00f3pez-Gambero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13195-024-01552-2","article-title":"A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer\u2019s disease","volume":"16","author":"Sakimura","year":"2024","journal-title":"Alzheimer's. Res. & Ther."},{"issue":"3","key":"10.1016\/j.biopha.2026.119629_bib59","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/S0006-291X(88)80520-5","article-title":"Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol","volume":"151","author":"Larner","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4425","key":"10.1016\/j.biopha.2026.119629_bib60","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1126\/science.505013","article-title":"Pyruvate dehydrogenase activation in adipocyte mitochondria by an insulin-generated mediator from muscle","volume":"206","author":"Jarett","year":"1979","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.biopha.2026.119629_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112956","article-title":"Rescue of Alzheimer\u2019s disease phenotype in a mouse model by transplantation of wild-type hematopoietic stem and progenitor cells","volume":"42","author":"Mishra","year":"2023","journal-title":"Cell. Rep."},{"issue":"22","key":"10.1016\/j.biopha.2026.119629_bib62","doi-asserted-by":"crossref","first-page":"13990","DOI":"10.1073\/pnas.222433299","article-title":"Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease","volume":"99","author":"Urbanc","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119629_bib63","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1523\/JNEUROSCI.23-06-02212.2003","article-title":"vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy","volume":"23","author":"McLellan","year":"2003","journal-title":"J. Neurosci."},{"issue":"21","key":"10.1016\/j.biopha.2026.119629_bib64","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2501527122","article-title":"Loss of insulin signaling in microglia impairs cellular uptake of A\u03b2 and neuroinflammatory response exacerbating AD-like neuropathology","volume":"122","author":"Chen","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119629_bib65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","article-title":"A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer's disease","volume":"30","author":"Baik","year":"2019","journal-title":"Cell. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11011-020-00622-2","article-title":"Insulin resistance: a connecting link between Alzheimer\u2019s disease and metabolic disorder","volume":"36","author":"Kshirsagar","year":"2021","journal-title":"Metab. brain Dis."},{"key":"10.1016\/j.biopha.2026.119629_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.687157","article-title":"Insulin resistance exacerbates Alzheimer disease via multiple mechanisms","volume":"15","author":"Wei","year":"2021","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119629_bib68","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of A\u03b2 oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119629_bib69","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0006-291X(02)00701-5","article-title":"Gq\/11 is involved in insulin-stimulated inositol phosphoglycan putative mediator generation in rat liver membranes: co-localization of Gq\/11 with the insulin receptor in membrane vesicles","volume":"295","author":"Sleight","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.biopha.2026.119629_bib70","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.bmcl.2005.02.061","article-title":"A fluorescent inositol phosphate glycan stimulates lipogenesis in rat adipocytes by extracellular activation alone","volume":"15","author":"Turner","year":"2005","journal-title":"Bioorg. & Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib71","article-title":"Myoinositol and D-chiro inositol in improving insulin resistance in obese male children: preliminary data","volume":"2016","author":"Mancini","year":"2016","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119629_bib72","article-title":"Compositions and methods for treating Alzheimer's disease and related disorders and promoting a healthy nervous system","author":"Pasinetti","year":"2014","journal-title":"Google Pat."},{"issue":"7","key":"10.1016\/j.biopha.2026.119629_bib73","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm1423","article-title":"Cyclohexanehexol inhibitors of A\u03b2 aggregation prevent and reverse Alzheimer phenotype in a mouse model","volume":"12","author":"McLaurin","year":"2006","journal-title":"Nat. Med."},{"issue":"21","key":"10.1016\/j.biopha.2026.119629_bib74","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220684120","article-title":"Loss of insulin signaling in astrocytes exacerbates Alzheimer-like phenotypes in a 5xFAD mouse model","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119629_bib75","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119629_bib76","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","article-title":"Inhibition of glycogen synthase kinase-3 ameliorates \u03b2-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies","volume":"288","author":"Avrahami","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119629_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.791666","article-title":"Meridianins rescue cognitive deficits, spine density and neuroinflammation in the 5xFAD model of Alzheimer\u2019s disease","volume":"13","author":"Rodr\u00edguez-Urgell\u00e9s","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","article-title":"Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains","volume":"141","author":"Vaillant-Beuchot","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib79","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12974-023-02914-7","article-title":"Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer\u2019s disease and brain aging","volume":"20","author":"Corraliza-Gomez","year":"2023","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib80","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/14737175.2017.1244482","article-title":"Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies","volume":"17","author":"Tramutola","year":"2017","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.biopha.2026.119629_bib81","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/NDT.S75717","article-title":"L-J. Activation of mTOR: a culprit of Alzheimer's disease?","volume":"11","author":"Cai","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.biopha.2026.119629_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149122","article-title":"Early spatial recognition memory deficits in 5XFAD female mice are associated with disruption of prefrontal parvalbumin neurons","volume":"1841","author":"Ganesh","year":"2024","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13853-8","article-title":"The impact of ageing reveals distinct roles for human dentate gyrus and CA3 in pattern separation and object recognition memory","volume":"7","author":"Dillon","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2026.119629_bib84","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nlm.2007.04.013","article-title":"Role of CA3 and CA1 subregions of the dorsal hippocampus on temporal processing of objects","volume":"88","author":"Hoge","year":"2007","journal-title":"Neurobiol. Learn. Mem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119629_bib85","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/ijms22020698","article-title":"Inhibitory neural network\u2019s impairments at hippocampal CA1 LTP in an aged transgenic mouse model of Alzheimer\u2019s disease","volume":"22","author":"Seo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119629_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2023.106343","article-title":"Insulin-induced long-term potentiation in the dentate gyrus of hippocampal formation","volume":"157","author":"Barut\u00e7u","year":"2023","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.biopha.2026.119629_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70186","article-title":"Intranasal Insulin Mitigates Memory Impairment and Neuroinflammation in a Mouse Model of Hippocampal Aging","volume":"13","author":"Nagarajan","year":"2025","journal-title":"Pharmacol. Res. & Perspect."},{"issue":"4","key":"10.1016\/j.biopha.2026.119629_bib88","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1007\/s12035-018-1231-5","article-title":"Biliverdin reductase-a mediates the beneficial effects of intranasal insulin in Alzheimer disease","volume":"56","author":"Barone","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib89","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci. data"},{"key":"10.1016\/j.biopha.2026.119629_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.615337","article-title":"Arbitration of approach-avoidance conflict by ventral hippocampus","volume":"14","author":"Bryant","year":"2020","journal-title":"Front. Neurosci."},{"issue":"27","key":"10.1016\/j.biopha.2026.119629_bib91","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1523\/JNEUROSCI.0336-15.2015","article-title":"Elimination of microglia improves functional outcomes following extensive neuronal loss in the hippocampus","volume":"35","author":"Rice","year":"2015","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.05.027","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A\u03b2 aggregation in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2026.119629_bib93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.physbeh.2014.05.041","article-title":"Behavioral and EEG changes in male 5xFAD mice","volume":"135","author":"Schneider","year":"2014","journal-title":"Physiol. & Behav."},{"issue":"3","key":"10.1016\/j.biopha.2026.119629_bib94","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrn3677","article-title":"Hippocampal synaptic plasticity, spatial memory and anxiety","volume":"15","author":"Bannerman","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"26","key":"10.1016\/j.biopha.2026.119629_bib95","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1523\/JNEUROSCI.1346-04.2004","article-title":"Double dissociation between the effects of peri-postrhinal cortex and hippocampal lesions on tests of object recognition and spatial memory: heterogeneity of function within the temporal lobe","volume":"24","author":"Winters","year":"2004","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119629_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089454","article-title":"Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"9","author":"Bhattacharya","year":"2014","journal-title":"PloS. One"},{"issue":"2","key":"10.1016\/j.biopha.2026.119629_bib97","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3233\/JAD-210523","article-title":"Sex differences in behavior and molecular pathology in the 5XFAD model","volume":"85","author":"Sil","year":"2022","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"48","key":"10.1016\/j.biopha.2026.119629_bib98","doi-asserted-by":"crossref","first-page":"18434","DOI":"10.1074\/jbc.RA118.005769","article-title":"ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease","volume":"293","author":"Sadleir","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib99","article-title":"Aromatase expression in the hippocampus of AD patients and 5xFAD mice","volume":"2016","author":"Prange-Kiel","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.biopha.2026.119629_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.816174","article-title":"Mitigating effect of estrogen in Alzheimer\u2019s disease-mimicking cerebral organoid","volume":"16","author":"Kim","year":"2022","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib101","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s10020-025-01178-6","article-title":"D-chiro-inositol effectively counteracts endometriosis in a mouse model","volume":"31","author":"Placidi","year":"2025","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib102","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12610-021-00146-4","article-title":"D-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study","volume":"31","author":"Nordio","year":"2021","journal-title":"Basic. Clin. Androl."},{"key":"10.1016\/j.biopha.2026.119629_bib103","article-title":"The improvement effect of D-chiro-inositol and ecklonia cava K. in the rat model of polycystic ovarian syndrome","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119629_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2022.111726","article-title":"Amyloid-\u00df plaque formation and BACE1 accumulation in the brains of a 5xFAD Alzheimer's disease mouse model is associated with altered distribution and not proteolysis of BACE1 substrates Sez6 and Sez6L","volume":"207","author":"Dominko","year":"2022","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.biopha.2026.119629_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115236","article-title":"DCI improves diabetic encephalopathy by modulating the BDNF\/NF-\u03baB\/GSK-3\u03b2 pathway","volume":"389","author":"Zhang","year":"2025","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/antiox15010059","article-title":"Neuroprotective Effect of D-Pinitol Against MPTP-Induced Parkinsonism in C57BL\/6J Mice","volume":"15","author":"Ju\u00e1rez-V\u00e1zquez","year":"2026","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.biopha.2026.119629_bib107","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119629_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109281","article-title":"The decreased astrocyte-microglia interaction reflects the early characteristics of Alzheimer\u2019s disease","volume":"27","author":"Liu","year":"2024","journal-title":"Iscience"},{"key":"10.1016\/j.biopha.2026.119629_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study","volume":"13","author":"Oblak","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib110","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41598-018-19699-y","article-title":"Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer\u2019s disease mouse model 5xFAD","volume":"8","author":"Boza-Serrano","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119629_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2024.100013","article-title":"Microglial activation states and their implications for Alzheimer's Disease","author":"Valiukas","year":"2025","journal-title":"J. Prev. Alzheimer's. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30487-6","article-title":"IL-1\u03b2, IL-6, TNF-\u03b1 and CRP in elderly patients with depression or Alzheimer\u2019s disease: systematic review and meta-analysis","volume":"8","author":"Ng","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/humu.20180","article-title":"TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels","volume":"26","author":"Laws","year":"2005","journal-title":"Human. Mutat."},{"issue":"2","key":"10.1016\/j.biopha.2026.119629_bib114","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s11033-012-2237-0","article-title":"Genetic polymorphism of interleukin 1\u03b2\u2212 511C\/T and susceptibility to sporadic Alzheimer\u2019s disease: a meta-analysis","volume":"40","author":"Yuan","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2026.119629_bib115","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3233\/JAD-200056","article-title":"IL-1\u03b2, IL-6, IL-10, and TNF \u03b1 single nucleotide polymorphisms in human influence the susceptibility to Alzheimer\u2019s disease pathology","volume":"75","author":"Babi\u0107 Leko","year":"2020","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib116","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11064-018-2517-8","article-title":"TNF\u03b1 and IL-1\u03b2 but not IL-18 suppresses hippocampal long-term potentiation directly at the synapse","volume":"44","author":"Prieto","year":"2019","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib117","article-title":"Tumor necrosis factor and interleukin-1\u03b2 modulate synaptic plasticity during neuroinflammation","volume":"2018","author":"Rizzo","year":"2018","journal-title":"Neural Plast."},{"issue":"1","key":"10.1016\/j.biopha.2026.119629_bib118","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11481-011-9331-2","article-title":"Chronic IL-1\u03b2-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer\u2019s disease without inducing overt neurodegeneration","volume":"7","author":"Matousek","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119629_bib119","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s13760-020-01369-4","article-title":"IL-6, IL-8 and IL-10 polymorphisms may impact predisposition of Alzheimer\u2019s disease: A meta-analysis","volume":"121","author":"Yang","year":"2021","journal-title":"Acta Neurol. Belg."},{"issue":"8","key":"10.1016\/j.biopha.2026.119629_bib120","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neurobiolaging.2003.10.009","article-title":"Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer\u2019s disease","volume":"25","author":"Arosio","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.biopha.2026.119629_bib121","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","article-title":"IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior","volume":"85","author":"Chakrabarty","year":"2015","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.biopha.2026.119629_bib122","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology","volume":"85","author":"Guillot-Sestier","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119629_bib123","article-title":"D-Chiro-Inositol Modulates Brain Insulin-Related Signaling and Reduces Amyloid Burden, Neuroinflammation and Cognitive Decline in Preclinical Models of Alzheimer's Disease","volume":"V2","author":"L\u00f3pez-Gambero","year":"2026","journal-title":"Mendeley Data"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:39:24Z","timestamp":1784529564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":123,"alternative-id":["S0753332226006657"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119629","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119629"}}